Mrs Amiee Kang
Bristol Myers Squibb, Princeton (United States of America)
Real-world assessment of antiplatelet treatment therapies for acute coronary syndrome (ACS) patients in the United States in a nationwide Electronic Health Record in 2018-2020
Event: ESC Congress 2023
Topic: Pharmacotherapy
Session: Real-world evidence in acute coronary syndromes (1)
Real-world assessment of anti-platelet therapies for recurrent stroke prevention in non-atrial fibrillation Japanese patients after recent ischemic stroke or transient ischemic attack
Event: ESC Congress 2022
Topic: Cardiovascular Pharmacotherapy
Session: Short and long-term antiplatelet therapy in clinical practice
Time at home among nonvalvular atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants versus warfarin
Event: ESC Congress 2021 - The Digital Experience
Topic: Oral Anticoagulation
Session: Atrial fibrillation e-posters
Comparative effectiveness and safety of non-VKA oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with differential treatment duration: an ARISTOPHANES study analysis
Event: ESC Congress 2019
Topic: Oral Anticoagulation
Session: Atrial fibrillation and oral anticoagulation 6
ESC 365 is supported by
